Associates L.L.C. Cdk Buys 215,000 Shares of KALA PHARMCTLS (NASDAQ:KALA) Stock

KALA PHARMCTLS (NASDAQ:KALA) major shareholder Associates L.L.C. Cdk purchased 215,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 20th. The stock was purchased at an average price of $15.00 per share, for a total transaction of $3,225,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Receive News & Ratings for KALA PHARMCTLS Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KALA PHARMCTLS and related companies with MarketBeat.com's FREE daily email newsletter.

KALA PHARMCTLS (NASDAQ KALA) traded down 0.980% during trading on Wednesday, reaching $19.705. The company had a trading volume of 50,557 shares. The firm’s market capitalization is $458.79 million. The firm’s 50 day moving average price is $16.45 and its 200 day moving average price is $16.45. KALA PHARMCTLS has a 12-month low of $10.43 and a 12-month high of $21.00.

TRADEMARK VIOLATION WARNING: “[[title]]” was first posted by [[site]] and is owned by of [[site]]. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at [[permalink]].

About KALA PHARMCTLS

Kala Pharmaceuticals Inc is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film.